Hologic (NSDQ:HOLX) said yesterday that a US International Trade Commission Administrative Law Judge ruled in their favor in an investigation into a patent infringement complaint filed against Fujifilm Holdings (TSE:4901).
Marlborough, Mass.-based Hologic said the complaint was related to x-ray mammography with tomosynthesis and other related mammography tech found in its Selenia Dimensions and 3Dimensions systems.
The judge ruled that Fujifilm infringed on all of the patents brought to trial and rejected Fujifilm’s defense against the patents, according to a Hologic press release. The judge also recommended an exclusion order to prevent further importation into the US and a cease-and-desist order to prevent sale and marketing in the US.
Hologic said that a final ruling from the ITC is scheduled to be issued by November 26.
“We are pleased that the Administrative Law Judge has upheld the integrity of our intellectual property against Fujifilm. We are confident that the Commission will uphold the decision to issue both an exclusion order and a cease-and-desist order covering Fujifilm’s infringing products. As the world leader and innovator in mammography, we will continue to vigorously protect our intellectual property, which drives innovation for our customers and patients,” breast and skeletal health prez Pete Valenti said in a press release.
Last week, a federal court jury awarded nearly $5 million in damages in a patent infringement lawsuit brought over their respective endometriosis devices.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.